Heintges T - Search Results

1

Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line.

Erhardt A, Hassan M, Heintges T, Häussinger D. Erhardt A, et al. Among authors: heintges t. Virology. 2002 Jan 20;292(2):272-84. doi: 10.1006/viro.2001.1227. Virology. 2002. PMID: 11878930 Free article.

2

Abrogation of hepatitis C virus NS3 helicase enzymatic activity by recombinant human antibodies.

Artsaenko O, Tessmann K, Sack M, Häussinger D, Heintges T. Artsaenko O, et al. Among authors: heintges t. J Gen Virol. 2003 Sep;84(Pt 9):2323-2332. doi: 10.1099/vir.0.19299-0. J Gen Virol. 2003. PMID: 12917452

3

SEN virus infection.

Sagir A, Kirschberg O, Heintges T, Erhardt A, Häussinger D. Sagir A, et al. Among authors: heintges t. Rev Med Virol. 2004 May-Jun;14(3):141-8. doi: 10.1002/rmv.421. Rev Med Virol. 2004. PMID: 15124231 Review.

4

Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase.

Tessmann K, Erhardt A, Häussinger D, Heintges T. Tessmann K, et al. Among authors: heintges t. J Virol Methods. 2002 May;103(1):75-88. doi: 10.1016/s0166-0934(02)00017-4. J Virol Methods. 2002. PMID: 11906735

5

SEN virus does not affect treatment response in hepatitis C virus coinfected patients but SEN virus response depends on SEN virus DNA concentration.

Sagir A, Adams O, Kirschberg O, Erhardt A, Heintges T, Haussinger D. Sagir A, et al. Among authors: heintges t. World J Gastroenterol. 2004 Jul 1;10(13):1893-7. doi: 10.3748/wjg.v10.i13.1893. World J Gastroenterol. 2004. PMID: 15222031 Free PMC article.

6

SEN virus seroprevalence in HIV positive patients: association with immunosuppression and HIV-replication.

Sagir A, Adams O, Oette M, Erhardt A, Heintges T, Häussinger D. Sagir A, et al. Among authors: heintges t. J Clin Virol. 2005 Jul;33(3):183-7. doi: 10.1016/j.jcv.2004.06.013. Epub 2004 Dec 10. J Clin Virol. 2005. PMID: 15911438

7

[Update hepatitis D].

Erhardt A, Starke C, Loerke J, Giesecke C, Heintges T, Häussinger D. Erhardt A, et al. Among authors: heintges t. Med Klin (Munich). 2006 Mar 22;101 Suppl 1:127-34. Med Klin (Munich). 2006. PMID: 16802537 German.

8

Treatment of chronic hepatitis delta with pegylated interferon-alpha2b.

Erhardt A, Gerlich W, Starke C, Wend U, Donner A, Sagir A, Heintges T, Häussinger D. Erhardt A, et al. Among authors: heintges t. Liver Int. 2006 Sep;26(7):805-10. doi: 10.1111/j.1478-3231.2006.01279.x. Liver Int. 2006. PMID: 16911462 Clinical Trial.

9

Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection.

Sagir A, Heintges T, Akyazi Z, Oette M, Erhardt A, Häussinger D. Sagir A, et al. Among authors: heintges t. Liver Int. 2007 Sep;27(7):954-9. doi: 10.1111/j.1478-3231.2007.01508.x. Liver Int. 2007. PMID: 17696934

10

Specific targeting of hepatitis C virus core protein by an intracellular single-chain antibody of human origin.

Karthe J, Tessmann K, Li J, Machida R, Daleman M, Häussinger D, Heintges T. Karthe J, et al. Among authors: heintges t. Hepatology. 2008 Sep;48(3):702-12. doi: 10.1002/hep.22366. Hepatology. 2008. PMID: 18697213 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters